Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C63667
http://purl.obolibrary.org/obo/NCIT_C63667
|
|---|---|
| Preferred Name | Mofarotene |
| Definitions |
An arotinoic acid derivative with a morpholine structure in the polar end group with differentiation inducing and antineoplastic activity. Like other retinoic acid agents, mofarotene binds to and activates retinoic acid receptors (RARs), thereby altering the expression of certain genes leading to cell differentiation and decreased cell proliferation in susceptible cells. In addition, this agent is able to inhibit melanoma cell motility.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An arotinoic acid derivative with a morpholine structure in the polar end group with differentiation inducing and antineoplastic activity. Like other retinoic acid agents, mofarotene binds to and activates retinoic acid receptors (RARs), thereby altering the expression of certain genes leading to cell differentiation and decreased cell proliferation in susceptible cells. In addition, this agent is able to inhibit melanoma cell motility. |
|---|---|
| prefLabel | Mofarotene
|
| label | Mofarotene
|
| code | C63667
|
| prefixIRI | NCIT:C63667
|
| in_subset | |
| Preferred_Name | Mofarotene
|
| FDA_UNII_Code | 8K3CVY8F8V
|
| Contributing_Source | FDA
|
| Chemical_Formula | C29H39NO2
|
| Maps_To | Mofarotene
|
| CAS_Registry | 125533-88-2
|
| Legacy Concept Name | Mofarotene
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0247161
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |